UPCYTE
DEAD

Serial Number

77691521

Owner

Medicyte GmbH

Attorney

Jennifer Fraser

Filing Date

Mar 16, 2009

Add to watchlist:

No watchlists yet
View on USPTO

UPCYTE Trademark

Serial Number: 77691521 • Registration: 4177445

UPCYTE is a trademark filed by Medicyte GmbH on March 16, 2009. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently no longer active.

Owner Contact Info

Medicyte GmbH (3 trademarks)

Im Neuenheimer Feld 581
69120 Heidelberg , DE

Entity Type: 99

Trademark Details

Filing Date

March 16, 2009

Registration Date

July 24, 2012

Published for Opposition

May 8, 2012

Cancellation Date

March 1, 2019

Goods & Services

Pharmaceutical and veterinary products for the treatment of cardiovascular disease, stroke, cancer, tumor, particularly by the way of cell and gene therapy; drugs for the treatment of cardiovascular disease, stroke, cancer, tumor, particularly by the way of cell and gene therapy in humans; protein supplements; proteins, nucleic acids, genes, and cells for medical diagnostics and treatment; medical, biological, chemical, biotechnological, and gene-technological products and preparations for medical use for the treatment of cardiovascular disease, stroke, cancer, tumor, particularly by the way of cell and gene therapy; diagnostic preparations for medical and veterinary use

Proteins, nucleic acids, genes, and cells for medical research purposes

Medical consultation; consulting services in the field of medicine, namely, human medicine, veterinary medicine, pharmacy, and gene-therapy in the nature of cardiovascular disease, stroke, cancer, tumor, particularly by the way of cell and gene therapy; medical consultation services provided via the Internet; medical care; medical information services, namely, consumer-authorized clinical laboratory testing services that report results directly to the patient

Diagnostic devices for medical and veterinary use, namely, for the diagnosing of cardiovascular disease, stroke, cancer, tumor, diseases of the pancreas, kidney and liver and neurodegenerative diseases

Scientific services in the nature of cell and gene therapy research services, provided to pharmaceutical, biotechnological, diagnostic, analytical, medical, or gene-technological laboratories, industrial facilities, and, research and development facilities, particularly concerning matters of cardiovascular disease, stroke, cancer and tumors; scientific consulting services in the field of chemistry, biotechnology, diagnostics, and gene-technology, namely, consulting services provided via the Internet; mission-oriented research in the field of chemistry, pharmacy, biotechnology, diagnostics, gene-technology, and medicine; services of a chemical laboratory; services of a medical laboratory; providing medical and scientific research information in the field of clinical trials

Filing History

CANCELLED SEC. 8 (6-YR)
Mar 1, 2019 C8..
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Jul 24, 2017 REM1
REGISTERED-PRINCIPAL REGISTER
Jul 24, 2012 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
May 8, 2012 NPUB
PUBLISHED FOR OPPOSITION
May 8, 2012 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Apr 18, 2012 NONP
LAW OFFICE PUBLICATION REVIEW COMPLETED
Apr 3, 2012 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 2, 2012 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 23, 2012 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 22, 2012 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 22, 2012 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 23, 2011 GNRN
NON-FINAL ACTION E-MAILED
Sep 23, 2011 GNRT
NON-FINAL ACTION WRITTEN
Sep 23, 2011 CNRT
ASSIGNED TO EXAMINER
Sep 23, 2011 DOCK
PREVIOUS ALLOWANCE COUNT WITHDRAWN
Sep 23, 2011 ZZZX
WITHDRAWN FROM PUB - OG REVIEW QUERY
Jul 29, 2011 PBCR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 21, 2011 PREV
APPROVED FOR PUB - PRINCIPAL REGISTER
Jul 20, 2011 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jul 19, 2011 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 19, 2011 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jul 19, 2011 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jan 19, 2011 GNRN
NON-FINAL ACTION E-MAILED
Jan 19, 2011 GNRT
NON-FINAL ACTION WRITTEN
Jan 19, 2011 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 14, 2010 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 14, 2010 CRFA
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Dec 14, 2010 ERSI
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Jun 15, 2010 GNS2
INQUIRY TO SUSPENSION E-MAILED
Jun 15, 2010 GNSI
SUSPENSION INQUIRY WRITTEN
Jun 15, 2010 CNSI
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jun 11, 2010 RCCK
ASSIGNED TO LIE
Jun 11, 2010 ALIE
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 2, 2009 GNS3
LETTER OF SUSPENSION E-MAILED
Dec 2, 2009 GNSL
SUSPENSION LETTER WRITTEN
Dec 2, 2009 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Dec 1, 2009 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 1, 2009 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Dec 1, 2009 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Jun 1, 2009 GNRN
NON-FINAL ACTION E-MAILED
Jun 1, 2009 GNRT
NON-FINAL ACTION WRITTEN
Jun 1, 2009 CNRT
ASSIGNED TO EXAMINER
Jun 1, 2009 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 19, 2009 NWOS
NEW APPLICATION ENTERED
Mar 19, 2009 NWAP